Hospira (HSP) Cash Flow Statement

Click line-items for a historical chart and %

Net income
Depreciation	94.9M
Amortization of intangible assets	24M
Stock-based compensation expense	29.1M
Undistributed equity income from affiliates
Deferred income taxes and other tax adjustments	22.7M
Impairment and other asset charges (benefits)
Gains on disposition of assets
Trade receivables	-1.8M
Inventories	-98.8M
Prepaid expenses and other assets	-2.8M
Trade accounts payable	-28.3M
Other liabilities	-91.2M
Other, net
Net Cash Provided by Operating Activities	186.2M
Capital expenditures (including instruments placed with or leased to customers)
Acquisitions, net of cash acquired
Purchases of intangibles and other investments	-20.1M
Proceeds from disposition of businesses and assets	0
Net Cash Used in Investing Activities
Other borrowings, net	-5.4M
Common stock repurchased
Excess tax benefit from stock-based compensation arrangements	37.6M
Proceeds from stock options exercised	50M
Net Cash (Used in) Provided by Financing Activities
Effect of exchange rate changes on cash and cash equivalents
Net change in cash and cash equivalents
Cash and cash equivalents at beginning of period	802.4M
Cash and cash equivalents at end of period	819.9M
Interest	51.5M
Income taxes, net of refunds	11.1M

Entities mentioned with HSP

View All Entities